A carregar...
Development of complement therapeutics for inhibition of immune-mediated red cell destruction
A major objective of my National Blood Foundation (NBF)-funded proposal was to produce recombinant soluble forms of a complement regulatory protein called complement receptor 1 (CR1) that carries the Knops blood group system antigens to perform antibody neutralization studies. By generating these re...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2005
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4797633/ https://ncbi.nlm.nih.gov/pubmed/16086799 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1537-2995.2005.00526.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|